Actively Recruiting
Watchful Waiting for Complete Responders to Therapy in Rectal Cancer
Led by Henry Ford Health System · Updated on 2024-01-29
30
Participants Needed
1
Research Sites
573 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this project is to determine if in a selected group of patients, at higher risk of wound dehiscence and other complications, treatment by local excision and management by a "watchful waiting" or an initial "non-operative management" approach, with an offer of radical resection only to those patients whose tumors demonstrate "regrowth" will maintain acceptable local control and overall survival rate for the whole cohort.
CONDITIONS
Official Title
Watchful Waiting for Complete Responders to Therapy in Rectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age ≥ 18 years
- Diagnosis of rectal invasive adenocarcinoma
- Tumor in the low rectum lying < 4 cm from the anal verge
- Clinical stage T3/N0-N1M0.
- Patients with low T2 who will need abdominal perineal resection are also eligible.
You will not qualify if you...
- Age less than 18 years
- Other forms of cancer
- Tumors >= 4 cm from the anal verge
- Tumors of other clinical stages than listed above
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ascension St. John Hospital
Detroit, Michigan, United States, 48236
Actively Recruiting
Research Team
A
Amr Aref, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here